Altimmune, Inc. Common Stock (NASDAQ: ALT) last traded at $3.11, up 5.42% on the session. The quote above updates while this page is open; the figures below are drawn from Altimmune, Inc. Common Stock’s own filings and are restated only when a new one is published.
Altimmune, Inc. Common Stock trades on NASDAQ under the ticker ALT. Its market capitalisation is $604.95 million.
Valuation measures for Altimmune, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $604.95M |
|---|---|
| Enterprise value | $594.95M |
| Price / sales | 14754.88 |
| Price / book | 1.28 |
| Beta | 1.54 |
Trailing-twelve-month figures tagged in Altimmune, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $41.0K |
|---|---|
| Net income (TTM) | -$91.76M |
| Operating margin | -244451.22% |
| Return on equity | -19.35% |
| Cash | $63.01M |
Range and volume for ALT over the past 52 weeks.
| 52-week high | $6.44 |
|---|---|
| 52-week low | $2.56 |
| Volume | 6.15M |
| Average volume | 4.35M |
| Previous close | $2.95 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.